STEVE ELMS - 24 May 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Director
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Issuer symbol
MRKR
Transactions as of
24 May 2022
Transactions value $
$0
Form type
4
Filing time
26 May 2022, 16:09:24 UTC
Previous filing
09 Mar 2022
Next filing
08 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Stock Option (Right to Buy) Award $0 +80,000 $0.000000 80,000 24 May 2022 Common Stock 80,000 $0.3377 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests on May 24, 2023, subject to the Reporting Person's continued service as a director through the vesting date.